chr8-47284058-G-C
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001080394.4(SPIDR):c.220G>C(p.Glu74Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000197 in 152,044 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001080394.4 missense
Scores
Clinical Significance
Conservation
Publications
- 46 XX gonadal dysgenesisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- ovarian dysgenesis 9Inheritance: Unknown, AR Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- male infertility with azoospermia or oligozoospermia due to single gene mutationInheritance: AR Classification: NO_KNOWN Submitted by: King Faisal Specialist Hospital and Research Center
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152044Hom.: 0 Cov.: 32 show subpopulations
GnomAD4 exome Cov.: 29
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152044Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74264 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.220G>C (p.E74Q) alteration is located in exon 3 (coding exon 3) of the SPIDR gene. This alteration results from a G to C substitution at nucleotide position 220, causing the glutamic acid (E) at amino acid position 74 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at